1. Introduction {#sec1-molecules-20-15781}
===============

Herbal pair (HP), as a basic unit in compatibility of traditional Chinese medicine (TCM), has been widely applied in folk medicine for thousands of years \[[@B1-molecules-20-15781],[@B2-molecules-20-15781]\]. Based on the compatibility mechanism, HP was composed of two relatively fixed herbs in the clinic. When the two fixed herbs are used together, interactions will occur so as to enhance the effect, reduce the toxicity or even remove the side effects compared with using a single herb alone \[[@B3-molecules-20-15781],[@B4-molecules-20-15781],[@B5-molecules-20-15781]\]. It has been proved that HP played an important role in the development of TCM \[[@B2-molecules-20-15781]\]. Compared with TCM compatibility, HP is not only based on the basic features and principles of TCM compatibility, but also easier to study due to their simpler chemical compositions \[[@B2-molecules-20-15781]\]. Therefore, the studies to HP chemistry will provide a different and relatively simple way for the study of prescription chemistry in TCM.

*Curcumae Rhizoma*--*Sparganii Rhizoma* (CR--SR) is a classical herbal pair in clinics. It is used for activating blood circulation to remove blood stasis. CR is good at breaking the Qi and dispersing the blood accumulation; SR is expert in removing blood stasis and dredging meridians \[[@B6-molecules-20-15781]\]. HP CR--SR was first recorded as Sanleng Wan in "*Jingyan Liangfang*" during the Qing dynasty, and has long been applied for the treatment of blood stasis and dysmenorrheal from the TCM perspective \[[@B7-molecules-20-15781],[@B8-molecules-20-15781]\]. So far, HP CR--SR has been involved as a TCM prescription preparation in Chinese pharmacopoeia, such as Fuke Tongjing Wan, Tongjingbao Keli, commonly being used to cure dysmenorrheal \[[@B9-molecules-20-15781]\]. Moreover, HP CR--SR was usually used to treat tumors in the TCM clinic, especially with respect to the gynecology aspect \[[@B10-molecules-20-15781],[@B11-molecules-20-15781],[@B12-molecules-20-15781]\].

At present, modern pharmacological research and clinical practices mostly focus on nonvolatile fractions of HP CR--SR, and it possesses extensive activities, including anti-cancer activity \[[@B13-molecules-20-15781],[@B14-molecules-20-15781],[@B15-molecules-20-15781],[@B16-molecules-20-15781]\], anti-inflammatory activity, and anti-thrombotic activity \[[@B17-molecules-20-15781]\]. The pharmacological activities of HP CR--SR essential oil are rarely reported and there is only one paper on the chemical components of HP CR--SR oil \[[@B18-molecules-20-15781]\]. It is noticed that CR essential oil has been recorded in the Pharmacopoeia of People's Republic of China (2010 edition), to treat gynecological oncology \[[@B9-molecules-20-15781],[@B19-molecules-20-15781],[@B20-molecules-20-15781],[@B21-molecules-20-15781]\]. The potential biological damage caused by free radicals is a leading contributor to chronic diseases, including cancer, diabetes mellitus, aging, and neurodegenerative disorders \[[@B22-molecules-20-15781],[@B23-molecules-20-15781]\] and the essential oil of CR was also good at antioxidant activity \[[@B24-molecules-20-15781],[@B25-molecules-20-15781]\]. The difference between the HP oil and CR oil has not been described from the perspective of chemical compositions and pharmacological activities to the best of our knowledge.

In this paper, the essential oils from CR, SR, and HP CR--SR have been extracted, respectively, and the components have been identified by gas chromatography-mass spectrometry (GC-MS). Meanwhile, their antioxidant activity was assessed by scavenging free radical ability, and antitumor activity, *in* *vitro*, was also evaluated with several cell models by MTT assay. The aim of this work was to clarify the compatibility of HP CR--SR in the TCM clinic from the view of chemical compositions and the pharmacological activities.

2. Results and Discussion {#sec2-molecules-20-15781}
=========================

Zedoary turmeric oil, the essential oil extracted from CR, is documented in the Chinese Pharmacopoeia (2010) that it has exhibited many potential medical characteristics in the aspects of anticancer and antivirus \[[@B26-molecules-20-15781],[@B27-molecules-20-15781]\]. In records of Chinese medical formula books or traditional application, CR is always combined with SR \[[@B7-molecules-20-15781],[@B8-molecules-20-15781]\]. The difference between HP oil and CR oil has been analyzed by GC-MS.

2.1. The Volatile Components of CR, SR and HP CR--SR {#sec2dot1-molecules-20-15781}
----------------------------------------------------

The essential oils of CR, SR, and HP CR--SR were extracted by hydrodistillation, and the yield was 6.0 mL/kg, 0.1 mL/kg, and 2.8 mL/kg, respectively. By means of the overall volume integration method, quantitative results of each component in pure chromatographic profiles of HP CR--SR, single herbs CR and SR can be obtained, as shown in [Table 1](#molecules-20-15781-t001){ref-type="table"}. In total, 66, 22, and 54 volatile components in CR, SR, and HP CR--SR were determined quantitatively, accounting for 75.416%, 91.857%, and 79.553%, respectively. The volatile chemical components in HP CR--SR are notably different from those of single herb CR or SR.

molecules-20-15781-t001_Table 1

###### 

Main chemical components of volatile oils from CR, SR, and HP CR--SR.

  No.      Name of Components                      RI                     CAS Identification Number   CR       SR       HP (CR--SR)                     
  -------- --------------------------------------- ---------------------- --------------------------- -------- -------- ------------- -------- -------- --------
  1        4-Hydroxy-4-methyl-2-pentanone          834                    123-42-2                    \-       \-       5.691         4.487    4.343    4.490
  2        Isoborneol                              1163                   124-76-5                    0.098    13.087   \-            \-       \-       \-
  3        Borneol                                 1172                   507-70-0                    0.229    13.327   \-            \-       \-       \-
  4        α-Terpineol                             1194                   98-55-5                     0.263    13.970   \-            \-       \-       \-
  5        (2*E*,4*E*)-Decadienol                  1300                   18409-21-7                  0.023    16.927   \-            \-       \-       \-
  6        Dimethoxy-(*Z*)-Citral                  1310                   75128-97-1                  0.042    17.168   \-            \-       \-       \-
  7        Geranyl acclate                         1355                   105-87-3                    0.025    18.379   \-            \-       \-       \-
  8        *neiso*-Dihydro carveol acetate         1360                   256332-36-2                 0.021    18.495   \-            \-       \-       \-
  9        (*Z*)-Trimenal                          1371                   300733-87-3                 0.012    18.794   \-            \-       \-       \-
  10       *trans*-Menth-6-en-2,8-diol             1379                   42370-41-2                  0.008    19.014   \-            \-       \-       \-
  11       Orcinol                                 1382                   504-15-4                    \-       \-       0.008         19.090   \-       \-
  12       β-Elemene                               1389                   515-13-9                    0.089    19.280   \-            \-       \-       \-
  13       Myltayl-(12)-ene                        1455                   79562-97-3                  0.286    20.937   \-            \-       \-       \-
  14       Ethyl-(2*E*,4*Z*)-decadienoate          1466                   3025-30-7                   0.760    21.285   \-            \-       \-       \-
  15       β-Chamigrene                            1473                   18431-82-8                  0.406    21.405   \-            \-       \-       \-
  16       α-Amorphen                              1479                   20085-19-2                  0.278    21.550   \-            \-       \-       \-
  17       α-Cuprenene                             1480                   29621-78-1                  \-       \-       0.011         21.576   \-       \-
  18       Isomethyl-α-(*E*)-Ionone                1488                   55093-42-0                  0.169    21.708   \-            \-       \-       \-
  19       Premnaspirodiene                        1490                   82189-85-3                  0.896    21.813   \-            \-       \-       \-
  20       *cis*-β-Gualene                         1493                   88-84-6                     0.096    21.896   \-            \-       \-       \-
  21       α-Sclinene                              1497                   473-13-2                    0.737    21.998   \-            \-       \-       \-
  22       Lilial                                  1503                   80-54-6                     \-       \-       0.025         22.148   \-       \-
  23       γ-Cadinene                              1521                   39029-41-9                  0.265    22.561   \-            \-       \-       \-
  24 \*    Silphiperfol-5-en-3-one B               1545                   199014-11-4                 \-       \-       \-            \-       0.113    23.148
  25 \*    Elemd                                   1548                   633-99-6                    \-       \-       \-            \-       0.117    23.204
  26       Hedycaryol                              1548                   21657-90-9                  0.483    23.204   \-            \-       \-       \-
  27       *trans*-Dauca-4(11),7-diene             1556                   000-00-0                    0.165    23.405   \-            \-       0.024    23.321
  28 \*    Germacrene B                            1556                   15423-57-1                  \-       \-       \-            \-       0.105    23.400
  29       Dodecanoic                              1556                   143-07-7                    \-       \-       0.049         23.415   \-       \-
  30       (*E*)-Nerolidol                         1559                   40716-66-3                  \-       \-       0.014         23.486   \-       \-
  31 \*    Eremophila ketone                       1561                   158930-41-7                 \-       \-       \-            \-       0.177    23.523
  32       Longicamphenylone                       1563                   58560-59-1                  0.256    23.526   \-            \-       \-       \-
  33       Germacrene D-4-ol                       1572                   74841-87-5                  0.125    23.787   \-            \-       \-       \-
  34       Caryophyllenyl alcohol                  1567                   000-00-0                    0.436    23.882   \-            \-       \-       \-
  35 \*    Caryolan-8-ol                           1576                   178737-45-6                 \-       \-       \-            \-       0.144    23.890
  36 \*    Thujopsan-2-β-ol                        1588                   150737-93-2                 \-       \-       \-            \-       0.132    24.033
  37       Fokiend                                 1588                   33440-00-5                  0.586    24.145   \-            \-       \-       \-
  38 \*    Globulol                                1590                   51371-47-2                  \-       \-       \-            \-       0.529    24.208
  39 \*    *trans*-β-Elemenone                     1593                   30824-86-3                  \-       \-       \-            \-       0.135    24.276
  40       Curzerenone                             1593                   20493-56-5                  26.078   24.481   \-            \-       39.937   24.481
  41 \*    β-Atlantol                              1607                   38142-56-2                  \-       \-       \-            \-       0.892    24.606
  42       Citronellyl pentanoata                  1607                   7540-53-6                   1.501    24.616   \-            \-       \-       \-
  43       Syringaldehyde                          1601                   134-96-3                    \-       \-       0.035         24.843   \-       \-
  44 \*    *epi*-Cedrol                            1619                   199003-73-2                 \-       \-       \-            \-       1.009    24.871
  45       Khusimone                               1619                   30557-76-7                  0.356    24.876   \-            \-       \-       \-
  46 \*    Isolongifolan-7-α-ol                    1622                   57566-26-4                  \-       \-       \-            \-       0.831    24.949
  47       Isolongifolanone                        1629                   26839-51-0                  0.600    24.962   \-            \-       \-       \-
  48       Torreyol (α-Muurolol)                   1627                   19435-97-3                  0.453    25.058   \-            \-       0.316    25.436
  49 \*    10-*epi*-γ-Eudesmol                     1624                   15051-81-7                  \-       \-       \-            \-       1.194    25.064
  50       γ-Eudesmol                              1632                   1209-71-8                   3.948    25.171   \-            \-       2.484    25.189
  51       2-Hydroxydiphenyl methane               1632                   28994-41-4                  \-       \-       0.102         25.192   \-       \-
  52 \*    *allo*-Aromadendrene epoxide            1638                   85160-81-2                  \-       \-       \-            \-       0.341    25.305
  53 \*    Hinesol                                 1640                   23811-08-7                  \-       \-       \-            \-       0.449    25.367
  54       Cubenol                                 1641                   21284-22-0                  0.443    25.374   \-            \-       \-       \-
  55       α-Muurold                               1643                   19435-97-3                  1.037    25.434   \-            \-       \-       \-
  56       Desmethoxy encecalin                    1648 (CR), 1649 (HP)   10913-07-1                  0.817    25.544   \-            \-       0.749    25.549
  57       β-Eudesmol                              1655 (SR), 1656 (HP)   473-15-4                    \-       \-       0.091         25.704   3.402    25.709
  58       α-Eudesmol                              1656                   473-16-5                    3.310    25.717   \-            \-       \-       \-
  59 \*    Selin-11-en-4-α-ol                      1659                   16641-47-7                  \-       \-       \-            \-       1.675    25.784
  60       *neo*-Intermeded                        1659                   5945-72-2                   0.478    25.788   \-            \-       \-       \-
  61       *ar*-Turmerone                          1661                   532-65-0                    \-       \-       0.099         25.836   \-       \-
  62 \*    Germacra-4(15),5,10(14)-trien-1-α-ol    1668                   81968-62-9                  \-       \-       \-            \-       0.488    25.909
  63       5-Hydroxy isobornyl isobutanoata        1664                   107783-33-5                 0.493    25.909   \-            \-       \-       \-
  64 \*    14-Hydoxy-9-*epi*-(*E*)-Caryophyllene   1669                   79768-23-5                  \-       \-       \-            \-       0.679    26.002
  65       Cadalene                                1672                   483-78-3                    0.639    26.078   \-            \-       \-       \-
  66       Germacrone                              1693                   6902-91-6                   2.778    26.560   \-            \-       4.822    26.563
  67 \*    Zizanal                                 1689                   82509-29-3                  \-       \-       \-            \-       0.235    26.665
  68       Sinensal                                1699                   60066-88-8                  0.382    26.686   \-            \-       \-       \-
  69       (*Z*)-β-Santalol                        1711                   77-42-9                     2.550    26.996   \-            \-       \-       \-
  70 \*    Mayurone                                1711                   4677-90-1                   \-       \-       \-            \-       0.560    26.961
  71       Curcumenol                              1720                   18431-84-6                  0.915    27.142   \-            \-       \-       \-
  72 \*    Longifold                               1722                   469-27-2                    \-       \-       \-            \-       0.498    27.183
  73       Isobicyclogermacrenal                   1723                   73256-82-3                  0.438    27.196   \-            \-       \-       \-
  74       Cryptomerione                           1729                   5988-72-7                   1.730    27.422   \-            \-       \-       \-
  75       Ambroxide                               1740 (CR), 1733 (HP)   6970-58-5                   1.597    27.575   \-            \-       0.374    27.415
  76 \*    Cyclocolorenone                         1740                   489-45-2                    \-       \-       \-            \-       0.354    27.568
  77       β-Acoradienol                           1761                   149496-35-5                 0.991    28.015   \-            \-       \-       \-
  78 \*    Squamuloseone                           1771                   34413-94-0                  \-       \-       \-            \-       0.856    28.396
  79 \*    14-Hydroxy-α-Muurolene                  1781                   135118-51-3                 \-       \-       \-            \-       0.856    28.396
  80       (2*E*,6*E*)-Methyl farnesoate           1783                   3675-00-1                   1.643    28.498   \-            \-       \-       \-
  81 \*    Vetivenic acid                          1792                   16203-25-1                  \-       \-       \-            \-       1.287    28.687
  82       8-Cedren-13-ol accetate                 1792                   18319-41-0                  2.781    28.695   \-            \-       \-       \-
  83       1-Octadecene                            1794                   112-88-9                    \-       \-       0.028         28.727   \-       \-
  84       14-Hydroxy-δ-Cadinene                   1802                   135118-52-4                 0.509    28.925   \-            \-       1.328    28.84
  85 \*    2-Ethylhexyl-Salicyate                  1810                   118-60-5                    \-       \-       \-            \-       0.314    29.073
  86       *iso*-Acorone                           1811                   6168-64-5                   0.396    29.083   \-            \-       \-       \-
  87       Acorone                                 1816                   10121-28-5                  0.405    29.210   \-            \-       \-       \-
  88 \*    Eudesm-7(11)-en-4-ol acetate            1831                   67987-89-7                  \-       \-       \-            \-       0.417    29.499
  89       Cyclopentadecanolide                    1834                   106-02-5                    \-       \-       0.348         29.556   \-       \-
  90       2,7(14),10-Bisabolatrien-1-ol-4-one     1837                   216372-16-6                 1.090    29.628   \-            \-       \-       \-
  91 \*    Phenyl ethyl octanoate                  1838                   5457-70-5                   \-       \-       \-            \-       0.658    29.637
  92       *n*-Hexadecanol                         1840                   36653-82-4                                    0.476         29.678   \-       \-
  93       (*E*)-Nerolidy isobutyrate              1844                   000-00-0                    0.504    29.772   \-            \-       \-       \-
  94       1,10-β-epoxy-6-Oxofuranoeyemophilane    1850                   5974-12-0                   1.224    29.887   \-            \-       0.962    29.880
  95       Cubitene                                1874 (CR), 1864 (HP)   66723-19-1                  0.396    30.380   \-            \-       0.451    30.181
  96       *cis*-Thujopsenic acid                  1865                   546-53-2                    1.015    30.199   \-            \-       \-       \-
  97 \*    Dihydro-Columellarin                    1905                   66873-38-9                  \-       \-       \-            \-       0.652    30.940
  98       Totarene                                1903                   000-00-0                    0.881    30.952   \-            \-       \-       \-
  99       Isopimara-9(11),15-dien                 1906                   39702-28-8                  0.432    31.021   \-            \-       \-       \-
  100 \*   11,12-dihydroxy Valencene               1919                   000-00-0                    \-       \-       \-            \-       0.155    31.281
  101      Methyl hexadecanoate                    1923                   112-39-0                    \-       \-       0.287         31.351   \-       \-
  102 \*   (3*E*)-Cembrene A                       1929                   31570-39-5                  \-       \-       \-            \-       0.121    31.481
  103      Cyclohexadecanolide                     1937                   109-29-5                    \-       \-       1.208         31.636   \-       \-
  104 \*   Columellarin                            1949                   66873-37-8                  \-       \-       \-            \-       0.435    31.860
  105      Hexadecanoic acid                       1967 (SR), 1955 (HP)   57-10-3                     \-       \-       38.634        32.214   0.266    31.990
  106      (3*Z*)-Cembrene A                       1964                   71213-92-8                  1.026    32.162   \-            \-       \-       \-
  107      Nootkatin                               1985                   4431-03-2                   1.775    32.573   \-            \-       \-       \-
  108 \*   *epi*-Catalponol                        1988                   70368-23-9                  \-       \-       \-            \-       1.348    32.625
  109      Ethyl hexadecanoate                     1991                   628-97-7                    \-       \-       1.828         32.687   \-       \-
  110      Polygodial                              2014                   6754-20-7                   0.285    33.117   \-            \-       0.523    32.851
  111      Dolabradiene                            2000                   134507-28-1                 0.747    32.858   \-            \-       \-       \-
  112 \*   Phyllocladene                           2015                   20070-61-5                  \-       \-       \-            \-       0.254    33.162
  113      Warburganal                             2016                   62994-47-2                  0.296    33.354   \-            \-       \-       \-
  114      Kaurene                                 2035                   34424-57-2                  0.714    33.526   \-            \-       \-       \-
  115 \*   Osthole                                 2040                   484-12-8                    \-       \-       \-            \-       0.551    33.607
  116 \*   Sclaredide                              2070                   564-20-5                    \-       \-       \-            \-       0.140    34.185
  117      Methyl linoleate                        2089 (SR), 2124 (HP)   112-63-0                    \-       \-       0.572         34.523   0.099    35.160
  118      Nootkatinol                             2095                   2492-08-2                   0.448    34.638   \-            \-       0.359    34.636
  119      *n*-Octadecanol                         2102                   112-92-5                    \-       \-       0.404         34.763   \-       \-
  120 \*   (*E*)-Isoeugenyl Benzyl ether           2116                   92666-21-2                  \-       \-       \-            \-       0.188    35.010
  121      Linoleic acid                           2124 (CR), 2285 (SR)   60-33-3                     0.561    35.531   37.981        35.329   \-       \-
  122 \*   Oroselone                               2131                   1760-27-6                   \-       \-       \-            \-       0.113    35.279
  123 \*   Abienol                                 2151                   1616-86-0                   \-       \-       \-            \-       0.112    35.662
  124      *n*-Docosene                            2163                   629-97-0                    \-       \-       3.196         35.874   \-       \-
  125      1-Docosene                              2170                   1599-67-3                   \-       \-       0.770         35.983   \-       \-
  Total                                                                                               75.416            91.857                 79.553   

RI refers to the retention index experimentally calculated using C7--C40 alkanes; φ is relative content; t is retention time; CR: *Curcumae Rhizoma*; SR: *Sparganii Rhizoma*; HP: herb pair CR--SR; -: Not detected; \* New constituents in herb pair CR--SR.

### 2.1.1. The Common Volatile Oils of HP and CR {#sec2dot1dot1-molecules-20-15781}

Several characteristics about the volatile chemical components in HP CR--SR can be seen from [Table 1](#molecules-20-15781-t001){ref-type="table"}. The main volatile chemical compounds in HP were curzerenone (39.937%), 4-hydroxy-4-methyl-2-pentanone (4.343%), germacrone (4.822%), β-eudesmol (3.402%), γ-eudesmol (2.484%), selin-11-en-4-α-ol (1.675%), *epi*-catalponol (1.348%), 14-hydroxy-δ-cadinene (1.328%), and vetivenic acid (1.287%). Thereinto, curzerenone, γ-eudesmol, and germacrone, as the common volatile oils of HP and CR, were also the higher content components of CR, accounting for 26.078%, 3.948%, and 2.778% respectively.

It is noteworthy that curcumenol has broad-spectrum anticancer activity \[[@B21-molecules-20-15781]\] and its content in HP oil was approximately two times higher than that of CR oil. Clinically, germacrone, as the official quality control marker for Zedoary turmeric oil, exhibited many pharmacological activities including anti-tumor activity, antiviral activity, and so on \[[@B28-molecules-20-15781],[@B29-molecules-20-15781]\]. Comparing with CR oil, the content of germacrone was increased in HP oil. Three common components in volatile oils of HP and SR were detected, including 4-hydroxy-4-methyl-2-pentanone (5.691%) and two other trace amount ingredients. The conclusion from the analysis above is that the volatile chemical components in HP CR--SR were not completely the same as those of single herb CR or SR.

### 2.1.2. The New Chemical Components of HP Volatile Oil {#sec2dot1dot2-molecules-20-15781}

There are 38 terpene alcohol-type components that were first found in HP, such as *epi*-cedrol (1.009%), 10-*epi*-γ-eudesmol (1.194%), selin-11-en-4-α-ol (1.675%), *epi*-catalponol (1.348%), vetivenic acid (1.287%), and so on. Those new component contents in HP reach up to 19.380%. The reports about their pharmacological activities are rather rare. The following compounds were worth mentioning: *epi*-cedrol, as a sesquiterpene alcohol, was also detected in *Artemisia annua* L, which could increase production of artemisinin by genetically-engineered methods \[[@B30-molecules-20-15781]\]. Selin-11-en-4-α-ol was the principle component in the oil of *Ononis Sicula* Guss., exhibited moderate antioxidant activity \[[@B31-molecules-20-15781]\]. It is the purportedly unique sesquiterpene compound, 10-*epi*-γ-eudesmol, that has been suggested as a marker for distinguishing the various cultivars and hybrids of *Pelargonium graveolens* \[[@B32-molecules-20-15781]\]. In addition, vetivenic acid was isolated by column chromatography and identified by NMR and CG-MS from *Vetiveria zizanioides* root, with promising antimicrobial effects \[[@B33-molecules-20-15781]\]. Interestingly, 2-ethylhexyl-salicyate, a significant sunscreen, was widely used in cosmetics and the medicine industry \[[@B34-molecules-20-15781]\]. Mayurone was first reported from *Mayur pankhi* and *Thujopsis dolabrata*, respectively, in 1965, and widely existed in many kinds of plants such as *Panax ginseng* and *Franco Thujaorientalis* \[[@B35-molecules-20-15781]\]. Considering the relatively high content and potential activity of those new components, it is inferred that they may impact on the activity and efficacy of HP oil.

Moreover, some volatile chemical compounds of CR, such as α-eudesmol (3.310%, 8-cedren-13-ol accetate (2.781%), (*Z*)-β-santalol (2.550%), nootratin (1.775%), and cryptomerione (1.730%), have not been detected in HP. In addition, hexadecanoic acid (38.634%), linoleic acid (37.981%), and *n*-docosene (3.196%), as the main chemical ingredients of SR volatile oil, have not been seen in HP. Possible reasons could be listed as follows: for one thing, some organic acids of SR, like succinic acid or sanleng acid, could play a role of solubilization effect, which have improved the constituents of CR dissolving out during the process of decocting the two single herbs, CR and SR \[[@B36-molecules-20-15781]\]. For another, it has a chance to easily interact among many active organic compounds, such as aldehydes, ketones, and alcohols, during the process of decocting CR and SR \[[@B3-molecules-20-15781],[@B18-molecules-20-15781],[@B37-molecules-20-15781],[@B38-molecules-20-15781],[@B39-molecules-20-15781],[@B40-molecules-20-15781]\]. In addition, the total contents of essential oils in CR and SR were reported to be quite uneven (2% and 0.04%, respectively) \[[@B36-molecules-20-15781]\], thus, it probably means that volatile oil of SR were covered by the volatile oil of CR when the compatibility ratio of two herbs is one to one.

2.2. DPPH Radical Scavenging Activity {#sec2dot2-molecules-20-15781}
-------------------------------------

Free radicals and oxidants could affect the metabolism of the body \[[@B41-molecules-20-15781]\]. Antioxidants have become important auxiliary products for health. DPPH is a useful reagent for investigating the free radical scavenging ability of compounds. The dose-response curve of DPPH radical scavenging activities of the essential oils from CR, SR, and HP CR--SR was distinct in [Figure 1](#molecules-20-15781-f001){ref-type="fig"}. The essential oil from HP CR--SR possessed the best activity with a rate of 90.6% under 5.0 mg/mL, and the essential oil from SR showed little DPPH radical scavenging activity.

Among total essential oils of the four samples, HP CR--SR possessed the highest antioxidant activity (IC~50~ = 0.59 ± 0.04 mg/mL). Compared with HP CR--SR oil, the volatile oil of CR showed moderate DPPH scavenging ability (IC~50~ = 1.39 ± 0.06 mg/mL), and the other two samples, SR and CR + SR, their IC~50~ were 8.39 ± 1.20 mg/mL and 2.20 ± 0.09 mg/mL, respectively. In addition, as a positive control, IC~50~ of vitamin C was 0.07 mg/mL in this condition.

In daily life, the increased dietary intake of natural antioxidants could reduce cancer mortality \[[@B42-molecules-20-15781],[@B43-molecules-20-15781],[@B44-molecules-20-15781]\]. Moreover, antioxidants not only selectively inhibit the proliferation of cancer cells but also do not harm normal cells \[[@B45-molecules-20-15781]\]. This means that the positive correlation exists between the antioxidant and antitumor activities.

![The DPPH free radical scavenging activities of essential oil from CR, SR, and HP CR--SR.](molecules-20-15781-g001){#molecules-20-15781-f001}

2.3. Anti-Tumor Activity {#sec2dot3-molecules-20-15781}
------------------------

The essential oils (CR, SR, and HP) were tested *in* *vitro* for their potential human tumor cell growth inhibitory effect on five human tumor cell lines (BGC823, A549, MCF-7, HeLa, and SKOV3), using MTT assay. The five human tumor cell lines are the most conventional tumor cell lines for the screening of antitumor activity, which are deemed to be high in veracity and reliability.

The concentration that inhibited cell vitality by 50% (IC~50~) is presented in [Table 2](#molecules-20-15781-t002){ref-type="table"}. Apparently, HP essential oil was the most effective in all tested cell lines, and presented IC~50~ values ranging from 32.32--74.84 μg/mL, except for human lung cancer cell lines (A549). The CR oil had less activity compared with HP oil, IC~50~ in the range between 31.57 and 162.87 μg/mL. The oil of SR had the lowest antitumor activity, and it showed nearly no efficacy in inhibiting, instead promoting five human tumors cell lines. On the other hand, the HeLa cell line was the most susceptible to the oils of CR and HP, while, among the tumor cell lines, the A549 was the most resistant one ([Figure 2](#molecules-20-15781-f002){ref-type="fig"}).

In particular, in order to further compare the activity differences between HP and two single herbs (CR and SR), group (CR + SR) is also set in the test. Different from group HP, the group (CR + SR) was made of the oils of CR and SR with 1:1 input quantity. Seeing from [Table 2](#molecules-20-15781-t002){ref-type="table"}, IC~50~ values of group HP are all lower than that of group (CR + SR) on human tumor cell growth inhibitory effect. Based on these findings, it can be speculated that the HP oil was remarkably better than the oil of any single one on anticancer activity.

molecules-20-15781-t002_Table 2

###### 

*In* *vitro* cytotoxic activities of the essential oils.

  Treatments   MCF-7 IC~50~ (μg/mL) ^a^   HeLa              SKOV3            BGC823         A549
  ------------ -------------------------- ----------------- ---------------- -------------- -----------------
  HP           74.84 ± 1.66               32.32 ± 5.31      66.12 ± 11.23    34.76 ± 1.82   708.24 ± 943.91
  CR + SR      184.51 ± 59.09             80.88 ± 10.06     131.02 ± 35.83   48.83 ± 2.76   \>1000
  SR           \>1000                     185.19 ± 187.88   \>1000           \>1000         \>1000
  CR           82.30 ± 5.36               31.57 ± 8.13      72.23 ± 5.20     44.11 ± 1.95   162.87 ± 43.36

^a^ Results are expressed as IC~50~ values (μg/mL) from three independent experiments performed in quadruplicate, measured by MTT assay after 24 h of incubation. The IC~50~ value, relative to untreated control, represents the concentration that inhibited cell vitality by 50%.

![Effect of the HP essential oil on cell viability of five cancer cell lines. Cells were treated with vehicle alone (0.5% DMSO) and specified concentrations of the essential oil in 0.5% DMSO for 24 h; cell viability was determined by the MTT assay as detailed in [Section 2](#sec2-molecules-20-15781){ref-type="sec"}. The values are represented as the percent of viable cells, with vehicle-treated cells regarded as 100% viable. Each point represents the mean of the values obtained from three independent experiments.](molecules-20-15781-g002){#molecules-20-15781-f002}

In the inhibitory effect assays on five tested human tumor cell lines, the essential oil of HP, in a dose-dependent manner, was the most effective compared to CR and SR oils. In other words, with the SR being put into HP, more effective ingredients in CR were dissolved out. This is highly consistent with chemical research results, especially being related with new components in HP oil. In spite of having found new constituents in HP oil, their pharmacological activities were less reported. Their activities should be focused on in the further studies.

3. Experimental Section {#sec3-molecules-20-15781}
=======================

3.1. Materials {#sec3dot1-molecules-20-15781}
--------------

Single herb CR and SR, with vinegar processing, were purchased from Hebei Anguo Medical Materials Corporation (Anguo, China), and identified as *Curcuma* *kwangsiensis* S.G. Lee et C.F. Liang and *Sparganium stoloniferum* Buch.-Ham., respectively, by Yuan Zhang from the Beijing University of Chinese Medicine, China. *n*-alkane standard solutions of C7--C40 (No. 49452-U) was purchased from SUPELCO (Bellefonte, PA, USA).

3.2. Extraction of the Essential Oils {#sec3dot2-molecules-20-15781}
-------------------------------------

A total of 100 g of CR and 100 g of SR single herbs were mixed and soaked with 1000 mL deionized water in a standard extractor for extracting volatile oil at room temperature for 12 h. Then, the essential oil was prepared by using the standard steam distillation method, according to the Chinese Pharmacopeia \[[@B9-molecules-20-15781]\]. The essential oil was collected and stored in a refrigerator at 4 °C before use. The essential oils of single herb CR or SR was extracted in the same method.

3.3. GC-MS Analysis {#sec3dot3-molecules-20-15781}
-------------------

Volatile oils were analyzed by an Agilent Technologies 5975C gas chromatograph (GC) equipped with a HP-5 MS capillary column (5% phenyl methyl Siloxane, 30 m × 0.25 mm i.d., 0.25 μm film thickness) and an HP 5973 mass selective detector (Agilent Technologies, Palo Alto, CA, USA) in the electron impact ionization mode (70 eV) under the following operating conditions: split ratio, 1:40; injection volume, 1.0 µL (TBME solution); inlet temperature, 260 °C; detector temperature, 260 °C; The oven temperature was programmed to start at 50 °C, increased at 5 °C/min to 100 °C, 100 °C increased at 3 °C/min to 150 °C, 150 °C increased at 5 °C/min to 250 °C, then held at 250 °C for 30 min. The helium (99.999%) carrier gas was kept at a constant flow of 1.2 mL/min.

3.4. Identification of Compounds {#sec3dot4-molecules-20-15781}
--------------------------------

The chemical ingredients of volatile oils were identified by the retention indices (RI), relative to a series of alkanes (C7--C40) at the same chromatographic conditions, consulting the Van Den Dool method \[[@B46-molecules-20-15781]\]. The data were analyzed by the Xcalibur 1.1 software (Thermo Fisher Scientific, Waltham, MA, USA, version 1.1), compared with the NIST/EPA/NIH database (2005, version 2.0d, Scientific Instrument Services, Inc., Ringoes, NJ, USA) and several references \[[@B47-molecules-20-15781],[@B48-molecules-20-15781],[@B49-molecules-20-15781],[@B50-molecules-20-15781]\]. The book "*Identification of Essential Oils Components by Gas Chromatogrtaphy*/*Mass Spectrometry*, 4th edition" \[[@B51-molecules-20-15781]\] played an equally vital role in identifying the individual compounds.

3.5. Anti-Tumor Activity {#sec3dot5-molecules-20-15781}
------------------------

Human gastric cancer cell lines (BGC823), human lung cancer cell lines (A549), human breast carcinoma cell lines (MCF-7), human cervix carcinoma cell lines (HeLa), and human ovary carcinoma cell lines (SKOV3) were purchased from Cell Resource Center, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. These cell lines were maintained in RPMI 1640 culture medium plus 10% calf serum and 100 U/mL penicillin, 75 U/mL streptomycin, in a 37 °C incubator supplied with 95% room air and 5% CO~2~.

The growth inhibitory effect of essential oils of HP, CR, and SR were measured using the standard MTT assay \[[@B52-molecules-20-15781],[@B53-molecules-20-15781]\]. Briefly, 100 μL samples of cell suspension (6 × 10^4^ cells/well) were cultivated in 96-cell plates for 18 h, as described. The samples of HP, CR, and SR oil were well dissolved in DMSO, respectively, followed ultrasonic vibration. Then, cells were incubated for 24 h with varying concentrations of the oil. After adding 100 μL MTT (1 mg/mL) solution to each well, the cells were further incubated at 37 °C for15 min, in a humidified atmosphere of 95% air/5% CO~2~. For MTT assay, the supernatant was thrown away and 200 μL DMSO was mixed into, the 96 wells plate was oscillated on micro-vibrator for an additional 10 min, the absorbency of each well was determined at λ 560 nm by an enzyme-immunoassay instrument (Beijing Perlong New Technology Co., Ltd., Beijing, China). Anti-tumor activity was expressed as the concentration of the drug inhibiting cell growth by 50% (IC~50~ value).

3.6. DPPH Radical Scavenging Activity {#sec3dot6-molecules-20-15781}
-------------------------------------

The DPPH radical scavenging activity was determined according to the method reported by Sharififar and others with some modifications, and compared with the activity of vitamin C as a positive control \[[@B54-molecules-20-15781]\]. An equal amount of (1 mL of 0.05 mg) DPPH solution in ethanol was mixed with 0.1 mL essential oil from CR, SR, and HP CR--SR in ethanol at various concentrations. After mixing, the solution was allowed to reach a steady state at room temperature for about 30 min. The DPPH radical scavenging activity was determined by the absorbance at λ 517 nm with the DNM9602A microplate reader (Beijing Perlong New Technology Co., Ltd., Beijing, China) and calculated by the following equation: where A~0~ is the absorbance of the control (blank, without extract) and A~1~ is the absorbance of the mixture with the essential oil.

4. Conclusions {#sec4-molecules-20-15781}
==============

In the present study, it is first reported that the essential oils of CR, SR, and HP CR--SR were comparatively explored from the aspects of the chemical compositions, antioxidant, and anticancer activities. The essential oil of HP is different from any, one of CR and SR, nor simply their superposition. Thirty-eight new components were detected in HP, and the relative contents of those new components reach up to 19.380%. Moreover, HP oil showed significant antioxidant and anticancer activities and the essential oils from four groups on antioxidant and anticancer activities were consistent, in order: SR \< CR + SR \< CR \< HP. It is well known that the essential oil of CR reveals prominent activities in the clinic, and it has been documented in different versions of Chinese Pharmacopoeia since 1977. Compared with CR oil, HP oil possessed the stronger antioxidant and anticancer activities. Thus, the volatile oil of HP has the better medicinal application prospect and deserves more attention in the pharmaceutical industry.

HP CR--SR belongs to a mutual reinforcement relationship according to seven compatibilities in TCM theory. Comparison and analysis of the essential oils of CR, SR, and HP CR--SR from chemical compositions and pharmacological activities, we can infer that CR may play a predominant role in HP, namely sovereign drug according to TCM theory. In spite of the low concentration of SR oil, it also plays an important part in HP through improving the dissolution of effective constituents and helping interact to produce new ingredients. In order to further illustrate the role of SR in HP, more focus can be concentrated on the change of HP essential oils (produced from different proportion compatibilities of CR and SR) on the chemical composition and pharmacological activities. Furthermore, it can be concluded that the chemical composition in HP CR--SR is responsible for its potent anticancer and antioxidant activities. Further investigations are in progress in our laboratory to identity the exact active principle and their action mechanism involved in anticancer and antioxidant activity.

Recently, the studies about herb pairs mostly concentrated on the content change of some main components and traced the origin of chemical constituents \[[@B55-molecules-20-15781],[@B56-molecules-20-15781],[@B57-molecules-20-15781],[@B58-molecules-20-15781]\]. Based on the integrity of TCM theory, it is suggested to be more focused on the content change of common components and the appearance of new constituents in herb pairs with different proportion compatibilities. Such experimental design and research approaches are encouraged to be applied in the further study on HP CR--SR decoction, in order to clarify the compatibility essence of HP.
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